The purpose of this study is to determine the safety and tolerability of inosine and its
ability to raise urate levels in blood and cerebral spinal fluid in individuals with early
Parkinson disease. This will determine whether it is appropriate to proceed with a larger
study of inosine's ability to modify the rate of disability progression in PD.
Phase:
Phase 2
Details
Lead Sponsor:
The Parkinson Study Group
Collaborators:
Harvard School of Public Health Harvard School of Public Health (HSPH) Massachusetts General Hospital Michael J. Fox Foundation for Parkinson's Research University of Rochester